View clinical trials related to Pigmented Lesions.
Filter by:Background: Melanoma mortality remains almost stable with a 0.2-1.5% increase annually despite rapid growth in reported melanoma incidence of 2.5-8.6% per year. Part of this discrepancy could be explained by overdiagnosis of melanoma, which may be as high as 54%. Histopathology is considered the gold standard diagnosis for melanocytic lesions despite only a moderately good intra- and inter-rater reliability. A possible explanation of why the inter-rater reliability is suboptimal could be that pathologists are inexperienced, extra cautious, or lack sufficient information needed for a reliable diagnosis.It has been hypothesized that the horizontal overview of a lesion through dermoscopy combined with clinical information on a given tumor, enables the generation of a tentative diagnosis that the pathologists can use to actively search for signs of pathology. Former research shows that clinicians' competence in dermoscopy can be improved by a short learning intervention, but that these skills aren't sustainable Aim: The aim of this study is to examine how acquired basic skills in dermoscopy of pigmented lesions and access to clinical images of a lesion, affect pathologists' confidence, accuracy and inter-rater reliability when interpreting melanocytic lesions.